Is Janux Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: JANX) stock is to Buy JANX stock.
Out of 2 analysts, 0 (0%) are recommending JANX as a Strong Buy, 2 (100%) are recommending JANX as a Buy, 0 (0%) are recommending JANX as a Hold, 0 (0%) are recommending JANX as a Sell, and 0 (0%) are recommending JANX as a Strong Sell.
What is JANX's forecast return on equity (ROE) for 2023-2025?
(NASDAQ: JANX) forecast ROE is -48.38%, which is considered weak.
What is JANX's Price Target?
According to 2 Wall Street analysts that have issued a 1 year JANX price target, the average JANX price target is $29.50, with the highest JANX stock price forecast at $35.00 and the lowest JANX stock price forecast at $24.00.
On average, Wall Street analysts predict that Janux Therapeutics's share price could reach $29.50 by Aug 10, 2024. The average Janux Therapeutics stock price prediction forecasts a potential upside of 196.78% from the current JANX share price of $9.94.
What is JANX's forecast return on assets (ROA) for 2023-2025?
(NASDAQ: JANX) forecast ROA is -42.42%, which is lower than the forecast US Biotechnology industry average of 12.08%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.